Editorial: NAFLD in Asia-clinical associations with advanced disease become clearer. Authors' reply

Affiliations

¹ Faculty of Medicine, University of Malaya, Malaysia.
² National University of Singapore, Singapore.
³ Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong.

Editorial

W-K Chan et al. Aliment Pharmacol Ther. 2018 Apr.

. 2018 Apr;47(7):1037-1038.

doi: 10.1111/apt.14572.

¹ Faculty of Medicine, University of Malaya, Malaysia.
² National University of Singapore, Singapore.
³ Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong.

No abstract available

Comment on

Clinical features and treatment of nonalcoholic fatty liver disease across the Asia Pacific region-the GO ASIA initiative.
Chan WK, Treeprasertsuk S, Imajo K, Nakajima A, Seki Y, Kasama K, Kakizaki S, Fan JG, Song MJ, Yoon SK, Dan YY, Lesmana L, Ho KY, Goh KL, Wong VW. Chan WK, et al. Aliment Pharmacol Ther. 2018 Mar;47(6):816-825. doi: 10.1111/apt.14506. Epub 2018 Jan 14. Aliment Pharmacol Ther. 2018. PMID: 29333610
Editorial: NAFLD in Asia-clinical associations with advanced disease become clearer.
Hardy T, McPherson S. Hardy T, et al. Aliment Pharmacol Ther. 2018 Apr;47(7):1035-1036. doi: 10.1111/apt.14557. Aliment Pharmacol Ther. 2018. PMID: 29512913 No abstract available.